Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
+917K
-
Total reported value, excl. options
-
$64.5M
-
Value change
-
+$810K
-
Number of buys
-
42
-
Number of sells
-
-33
-
Price
-
$2.95
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q1 2015
91 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q1 2015.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 52.3M outstanding shares and own 41.83% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.21M shares), DIMENSIONAL FUND ADVISORS LP (1.8M shares), BlackRock Institutional Trust Company, N.A. (1.53M shares), First Light Asset Management, LLC (1.32M shares), RENAISSANCE TECHNOLOGIES LLC (1.21M shares), VANGUARD GROUP INC (1.14M shares), THOMSON HORSTMANN & BRYANT INC (1.06M shares), BlackRock Fund Advisors (1.01M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (835K shares), and Allianz Asset Management AG (818K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.